← SynDRA
SULFACETAMIDE
SynDRA canonical compound SYN0000200 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | PABA antagonist |
| Indication | conjunctivitis |
| Disease area | ophthalmology |
All known targets
Mechanisms of action (all sources)
- PABA antagonist
- Inhibitor
- folP INHIBITOR
Drug classes
- Sulfonamide Antibacterial
- Anti-Bacterial Agents
- Anti-Infective Agents
- Anti-Infective Agents, Local
- Anti-Infective Agents, Urinary
ATC classes
- S01A · ANTIINFECTIVES
- D10A · ANTI-ACNE PREPARATIONS FOR TOPICAL USE
Cross-references
Synonyms
- acetosulfamin
- acetosulfamine
- formosulfacetamide
- N-Acetylsulfanilamide
- N-Sulfanilylacetamide
- sulfacet
- sulfacetimide
- sulphacetamide
- sulfacetamide sodium
- sulfacetamide sodic hydrate
- Sulfacetamide (triple sulfa)
- Triple sulfa (sulfacetamide)
- Sulfacetamida
- Fml-s
- Sulfacetamidum
- Sulster
- Urosulfon
- NSC-63871
- Sulfacetamide (triple sulfa) component of sultrin
- Sulfacetamide component of gyne-sulf
- Sulfacetamide component of sultrin
- Sulfacetamide component of trysul
- Sulfacetamide component of vagilia
- Acetocid
- Acetosulfamin
- Acetosulfamine
- Albamine
- Albucid
- Alesten
- Cetamide
- Formosulfacetamide
- Klaron
- Oclucid
- Ophthacet
- Region
- SULSTER
- Sebizon
- Solfacetamide
Reported adverse events
- Stevens-Johnson syndrome
- Keratitis
Look up SULFACETAMIDE in the interactive SynDRA portal →